SCHEMBL19616623

SCHEMBL19616623

CC(C)c1ccc2[nH]nc(C3CCCCO3)c2c1Br

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.33
▸ MAPK9 P45984 1/20 0.33
▸ MAPK10 P53779 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19616582 0.84 MAPK8 (0.30) MAPK8MAPK9MAPK10
SCHEMBL19616876 0.81 PRKAB2 (0.32) —
SCHEMBL19616539 0.81 CHUK (0.36) —
SCHEMBL19616692 0.79 — —
SCHEMBL31586483 0.71 GAA (0.38) MAPK8MAPK9
SCHEMBL3402451 0.71 GAA (0.44) MAPK10
SCHEMBL31190772 0.71 PIM1 (0.33) —
SCHEMBL14721720 0.69 PRKAG1 (0.33) —
SCHEMBL6152152 0.69 CYP1A2 (0.32) —
SCHEMBL15740705 0.68 PIM1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710439-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2020-09-23 — — EP disclosed
EP-3458445-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2019-03-27 — — EP disclosed
WO-2017201161-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2017-11-23 — — WO disclosed
Send feedback